Primary intraventricular hemorrhage outcomes in the CLEAR III trial.
Sarah E NelsonW Andrew MouldDheeraj GandhiRichard E ThompsonSarah SalterRachel DlugashIssam A AwadDaniel F HanleyWendy ZiaiPublished in: International journal of stroke : official journal of the International Stroke Society (2020)
In CLEAR III, primary intraventricular hemorrhage patients who survived achieved better long-term outcomes than surviving secondary intraventricular hemorrhage patients with similar mortality. Outcomes and safety were similar between primary intraventricular hemorrhage patients receiving alteplase and those receiving saline.